IBCG_BladderCA Profile Banner
IBCG Profile
IBCG

@IBCG_BladderCA

Followers
1K
Following
3K
Media
15
Statuses
2K

We (the IBCG, International Bladder Cancer Group) are a group who are devoted to positively affecting the care of bladder cancer patients globally.

Joined January 2016
Don't wanna be here? Send us removal request.
@UroDocAsh
Ashish M. Kamat, MD, MBBS
10 hours
@tompowles1 @PGrivasMDPhD @SimaPorten @paolo_gontero @MariaJRibal @MaxKates @mouwlab @AndreaNecchi (4/5) πŸ’Š Adjuvant Therapy Framework β€’ Prefer chemotherapy > BCG, especially during shortages. β€’ 0 factors: single peri-operative dose. β€’ 1–2 factors: add 6-wk induction chemo Β± maintenance (1 yr) or BCG. β€’ β‰₯3 factors: induction + 1 yr maintenance BCG. β€’
0
1
5
@LauraBukavinaMD
Laura Bukavina
2 days
In anticipation of #esmo2025 please find a perfect summary of #bladdercancer trials made by our @UroOnc fellow superstar @hjwang26 .. looking forward to πŸ“ŠπŸ§‘β€πŸ’» ALBAN, POTOMAC @IBCG_BladderCA @CleClinicUro ..
2
17
88
@urotoday
UroToday.com
3 days
#SunRISe1 Trial of the #TAR200 gemcitabine delivery system. @siadaneshmand @uscnorris joins @UroDocAsh @MDAndersonNews to discuss the SunRISe-1 trial results that led to FDA approval of the TAR-200 device (INLEXZO) for BCG-unresponsive #BladderCancer. #WatchNow on UroToday >
1
2
7
@IBCG_BladderCA
IBCG
4 days
IBCG is pleased to welcome Dr. Sarah P. Psutka MD MS FACS to our Scientific Advisory Board. Dr. Psutka is Associate Professor of Urology at the University of Washington, Fred Hutchinson Cancer Center where she is the SUO Fellowship Program Director. She is internationally
2
2
22
@ParamMariappan
Prof Param Mariappan FRCS(Urol), PhD
6 days
0
2
6
@shilpaonc
Shilpa Gupta
6 days
0
1
5
@UrogerliMD
Roger Li
7 days
@apolo_andrea kicking off Day 2 of the Mexican Bladder Cancer Guidelines discussion @IBCG_BladderCA
0
6
8
@UrogerliMD
Roger Li
7 days
That’s a wrap for the Mexican Bladder Cancer Guidelines Project! Great 2 days spent with friends from Mexico to understand the practice patterns in Mexico and to tailor the guidelines accordingly. Thank you to the inimitable #DrArturoMendoza for the invitation and organization
3
3
15
@PGrivasMDPhD
Petros Grivas
10 days
Indeed such an Excellent choice @AndreaNecchi @UroDocAsh @IBCG_BladderCA
0
1
5
@PGrivasMDPhD
Petros Grivas
10 days
@UroDocAsh
Ashish M. Kamat, MD, MBBS
11 days
0
1
8
@urotoday
UroToday.com
8 days
International initiative to define and quantify local bladder side effects. @pjhensley11 @Urology_KU joins @UroDocAsh @MDAndersonNews to discuss the development of a comprehensive bladder toxicity index for intravesical therapies. #WatchNow on UroToday > https://t.co/oVH3alTfeC
0
2
7
@UrogerliMD
Roger Li
8 days
Looking forward to working with colleagues from Mexico on developing the Mexican Bladder Cancer Guidelines @IBCG_BladderCA @UroDocAsh #ArturoMendoza @smumexico
1
3
21
@UroDocAsh
Ashish M. Kamat, MD, MBBS
8 days
Kicking off the Mexican Guidelines meeting with IBCG team Energizing to see such strong engagement and enthusiasm as we work together to shape evidence-based standards for bladder cancer care in Mexico #BladderCancer #GlobalOncology @IBCG_BladderCA
1
8
36
@UrogerliMD
Roger Li
7 days
0
2
6
@PGrivasMDPhD
Petros Grivas
7 days
Fantastic work & mission! @IBCG_BladderCA @UroDocAsh
@UroDocAsh
Ashish M. Kamat, MD, MBBS
8 days
Kicking off the Mexican Guidelines meeting with IBCG team Energizing to see such strong engagement and enthusiasm as we work together to shape evidence-based standards for bladder cancer care in Mexico #BladderCancer #GlobalOncology @IBCG_BladderCA
0
3
10
@IBCG_BladderCA
IBCG
10 days
IBCG is pleased to welcome Prof. Andrea Necchi to our Scientific Advisory Board. Professor Necchi is associate professor of oncology at Vita-Salute San Raffaele University in Milan, Italy, and Director of GU Medical Oncology at San Raffaele Hospital, Milan, Italy, and is
3
2
20